These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 20178041

  • 1. PPAR receptor activation: Experimental studies on cardiac structure and function.
    Bishop-Bailey D.
    Curr Opin Investig Drugs; 2010 Mar; 11(3):283-8. PubMed ID: 20178041
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA, Piqueras L, Bishop-Bailey D.
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [Abstract] [Full Text] [Related]

  • 3. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
    Bishop-Bailey D, Bystrom J.
    Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B, van Bilsen M.
    Circ Res; 2003 Mar 21; 92(5):518-24. PubMed ID: 12600885
    [Abstract] [Full Text] [Related]

  • 5. PPARs and angiogenesis.
    Bishop-Bailey D.
    Biochem Soc Trans; 2011 Dec 21; 39(6):1601-5. PubMed ID: 22103494
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD, Wagner N.
    Pharmacol Ther; 2010 Mar 21; 125(3):423-35. PubMed ID: 20026355
    [Abstract] [Full Text] [Related]

  • 7. [PPARs-mediated intracellular signal transduction].
    Fujii H.
    Nihon Rinsho; 2005 Apr 21; 63(4):565-71. PubMed ID: 15828221
    [Abstract] [Full Text] [Related]

  • 8. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.
    Pharmacol Rev; 2006 Dec 21; 58(4):726-41. PubMed ID: 17132851
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM, Sanders DA, Maier LM, Stock DM, Kealey T.
    Br J Dermatol; 2004 Oct 21; 151(4):766-75. PubMed ID: 15491415
    [Abstract] [Full Text] [Related]

  • 10. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G, Torres N, Tovar AR.
    Rev Invest Clin; 2004 Oct 21; 56(3):351-67. PubMed ID: 15612519
    [Abstract] [Full Text] [Related]

  • 11. [Nuclear Receptor PPARs and magnesium].
    Fujii H.
    Clin Calcium; 2005 Nov 21; 15(11):52-64. PubMed ID: 16272614
    [Abstract] [Full Text] [Related]

  • 12. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV, Urrutia CR, Martinez GR, Loyola G, Bronfman M.
    J Cell Physiol; 2008 Nov 21; 217(2):367-76. PubMed ID: 18543250
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N, Duez H, Fruchart JC, Staels B.
    Circ Res; 2004 May 14; 94(9):1168-78. PubMed ID: 15142970
    [Abstract] [Full Text] [Related]

  • 14. PPAR ligands: are they potential agents for cardiovascular disorders?
    Balakumar P, Rose M, Singh M.
    Pharmacology; 2007 May 14; 80(1):1-10. PubMed ID: 17496434
    [Abstract] [Full Text] [Related]

  • 15. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P, Fruchart JC, Staels B.
    Nat Clin Pract Endocrinol Metab; 2007 Feb 14; 3(2):145-56. PubMed ID: 17237841
    [Abstract] [Full Text] [Related]

  • 16. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, Di Loreto S.
    Neuroscience; 2005 Feb 14; 130(2):325-37. PubMed ID: 15664689
    [Abstract] [Full Text] [Related]

  • 17. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B, Dembińska-Kieć A, Olszanecka A, Bodzioch M, Kawecka-Jaszcz K.
    J Physiol Pharmacol; 2005 Jun 14; 56(2):149-62. PubMed ID: 15985699
    [Abstract] [Full Text] [Related]

  • 18. PPARs as therapeutic targets in cardiovascular disease.
    van Bilsen M, van Nieuwenhoven FA.
    Expert Opin Ther Targets; 2010 Oct 14; 14(10):1029-45. PubMed ID: 20854178
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul 14; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 20. [PPARs and heart diseases].
    Takano H, Komuro I.
    Nihon Rinsho; 2005 Apr 14; 63(4):659-64. PubMed ID: 15828234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.